Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes

The current management of Type 2 Diabetes Mellitus (T2DM) includes incretin-based treatments able to enhance insulin secretion and peripheral insulin sensitivity as well as improve body mass, inflammation, plasma lipids, blood pressure, and cardiovascular outcomes. Dietary Free Fatty Acids (FFA) reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Patti, Angelo Maria, Giglio, Rosaria Vincenza, Papanas, Nikolaos, Serban, Dragos, Stoian, Anca Pantea, Pafili, Kalliopi, Al Rasadi, Khalid, Rajagopalan, Kanya, Rizvi, Ali A., Ciaccio, Marcello, Rizzo, Manfredi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779029/
https://www.ncbi.nlm.nih.gov/pubmed/35056417
http://dx.doi.org/10.3390/medicina58010109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779029/
https://www.ncbi.nlm.nih.gov/pubmed/35056417
http://dx.doi.org/10.3390/medicina58010109

Ejemplares similares